GSK CEO Sees China’s Wider Drug Access Overcoming Price-Cap Onus
This article was originally published in PharmAsia News
Executive Summary
GSK is betting China’s continuing healthcare reforms will increase demand for drugs enough to overcome the onus of price caps, so it plans to hire “a few hundred more” sales reps in the country.